CAR-T Cell Therapy

Researchers have discovered a new role that a protein known as NKG7 plays in regulating cell resistance and fighting tumors in certain types of cancer.

Dr. Allison Rosenthal, a Mayo Clinic hematologist specializing in lymphoma, answered questions about the disease in a Reddit AMA.

Dr. Richard Vile, a Mayo Clinic immunologist and cancer researcher, explains how CAR-T cell therapy works, including the benefits, risks and realities of treatment.

Drs. Haidong Dong and Svetomir Markovic, Mayo Clinic immunologists, discuss how immunotherapy works, its benefits and risks, and why they’re excited about its future.

Over 25 years as a Mayo Clinic patient, Ann Mackey finds answers, treatment for multiple bouts of cancer, and a way to give back.

Dr. Sikander Ailawadhi says physicians are identifying, monitoring and eliminating blood cancer earlier thanks to new treatments.

Read about the research being conducted to improve CAR-T cell therapy and expand its capabilities to treat more conditions.

Researchers have uncovered a new reason CAR-T cell therapy fails in some patients, fueling new strategies to improve the treatment's outcome.

Mayo Clinic researchers are collaborating to develop CAR-T cell therapy for solid tumors in thyroid cancer.

After Sylvester Pinckney's lymphoma returned, chimeric antigen receptor-T cell therapy at Mayo Clinic put his cancer back in remission.